Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.84 USD | -4.26% |
|
+0.27% | +35.53% |
24/06 | ITeos Therapeutics, Inc.(NasdaqGM:ITOS) added to S&P Biotechnology Select Industry Index | CI |
17/06 | GSK: Phase III study with iTeos begins | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.53% | 55Cr | |
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.6TCr | |
-23.86% | 1.94TCr | |
-19.03% | 1.59TCr | |
-20.90% | 1.51TCr | |
-46.14% | 1.51TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.39TCr |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- iTeos Therapeutics : Wedbush Adjusts ITeos Therapeutics' Price Target to $50 From $52, Keeps Outperform Rating